These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31484868)

  • 1. Impact of Residual Stenosis on the Angiographic Edge Restenosis of a Second-Generation Drug-Eluting Stent.
    Kozuma K; Shinozaki T; Kozuma K; Kashiwabara K; Oba K; Aoki J; Awata M; Nanasato M; Shiode N; Tanabe K; Yamaguchi J; Kimura T; Matsuyama Y
    Int Heart J; 2019 Sep; 60(5):1050-1060. PubMed ID: 31484868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariable prediction model to estimate the probability of restenosis at proximal edge after 2nd-generation drug-eluting-stent implantation: development and internal validation using a quantitative coronary angiography from the post-marketing surveillance studies of everolimus-eluting stent in Japan.
    Kozuma K; Kozuma K; Shinozaki T; Kashiwabara K; Oba K; ; ; Matsuyama Y
    Cardiovasc Interv Ther; 2021 Apr; 36(2):190-197. PubMed ID: 32306206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
    Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up study.
    Kaul U; Unverdorben M; Degenhardt R; Seth A; Bahl VK; Hiremath SM; Chandra P; Mullesari AS; Sandhu PS; Rao S; George O; Ackermann H; Boxberger M
    Indian Heart J; 2013; 65(5):510-7. PubMed ID: 24206873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late restenosis following sirolimus-eluting stent implantation.
    Kuriyama N; Kobayashi Y; Nakama T; Mine D; Nishihira K; Shimomura M; Nomura K; Ashikaga K; Matsuyama A; Shibata Y
    JACC Cardiovasc Interv; 2011 Jan; 4(1):123-8. PubMed ID: 21251639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.
    Kang SJ; Cho YR; Park GM; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Park SW; Park SJ
    Am J Cardiol; 2013 May; 111(10):1408-14. PubMed ID: 23433757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Angiographic Residual Stenosis on Clinical Outcomes After New-Generation Drug-Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials.
    Watanabe H; Morimoto T; Shiomi H; Natsuaki M; Kawai K; Kozuma K; Igarashi K; Kadota K; Tanabe K; Morino Y; Hibi K; Akasaka T; Abe M; Suwa S; Muramatsu T; Kobayashi M; Dai K; Nakao K; Tarutani Y; Fujii K; Kimura T;
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29960987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in patients treated with the zotarolimus-eluting stent at a tertiary medical center.
    Shammas NW; Shammas GA; Lemke J; Miller S; Meriner S
    J Invasive Cardiol; 2012 Jun; 24(6):256-60. PubMed ID: 22684377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan.
    Aoki J; Kozuma K; Awata M; Nanasato M; Shiode N; Tanabe K; Yamaguchi J; Kusano H; Nie H; Kimura T;
    Cardiovasc Interv Ther; 2019 Jan; 34(1):40-46. PubMed ID: 29484580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents.
    Billinger M; Räber L; Hitz S; Stefanini GG; Pilgrim T; Stettler C; Zanchin T; Pulver C; Pfäffli N; Eberli F; Meier B; Kalesan B; Jüni P; Windecker S
    Am Heart J; 2012 May; 163(5):876-886.e2. PubMed ID: 22607867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
    Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
    Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late target lesion revascularization after implantation of sirolimus-eluting stent.
    Hong MK; Mintz GS; Lee CW; Park DW; Lee SW; Kim YH; Jung IH; Kim SH; Cheong SS; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):299-303. PubMed ID: 17985380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term serial angiographic outcomes after sirolimus-eluting stent implantation.
    Ko E; Nasu K; Habara M; Tanaka N; Terashima M; Kinoshita Y; Tsuchikane E; Asakura Y; Katoh O; Suzuki T
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E29-35. PubMed ID: 22517538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.
    van Bommel RJ; Lemmert ME; van Mieghem NM; van Geuns RJ; van Domburg RT; Daemen J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):E21-E28. PubMed ID: 28500738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.